James N. Hollenhorst
Directeur/Bestuurslid bij Gen9, Inc.
Profiel
James N.
Hollenhorst is currently a Director at Gen9, Inc. He was previously a Senior Director-Technology at Agilent Technologies, Inc. Hollenhorst holds a graduate degree and a doctorate from Stanford University and an undergraduate degree from the University of Minnesota.
Actieve functies van James N. Hollenhorst
Bedrijven | Functie | Begin |
---|---|---|
Gen9, Inc.
Gen9, Inc. BiotechnologyHealth Technology Gen9, Inc. engages in the development of synthetic biology technologies. It transforms synthetic biology by creating technologies to increase innovation within several industries including biopharmaceuticals, fine chemicals and bio-fuels. The company was founded by Joseph M. Jacobson, George Church and Drew Endy in 2009 and is headquartered in Cambridge, MA. | Directeur/Bestuurslid | - |
Eerdere bekende functies van James N. Hollenhorst
Bedrijven | Functie | Einde |
---|---|---|
AGILENT TECHNOLOGIES, INC. | Corporate Officer/Principal | - |
Opleiding van James N. Hollenhorst
University of Minnesota | Undergraduate Degree |
Stanford University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
AGILENT TECHNOLOGIES, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Gen9, Inc.
Gen9, Inc. BiotechnologyHealth Technology Gen9, Inc. engages in the development of synthetic biology technologies. It transforms synthetic biology by creating technologies to increase innovation within several industries including biopharmaceuticals, fine chemicals and bio-fuels. The company was founded by Joseph M. Jacobson, George Church and Drew Endy in 2009 and is headquartered in Cambridge, MA. | Health Technology |